These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 13586004)
1. [Ink caustic erosion of the eye]. KRAHNSTOVER M Dtsch Gesundheitsw; 1958 Sep; 13(38):1201-3. PubMed ID: 13586004 [No Abstract] [Full Text] [Related]
2. [A case of eye injury caused by methyl violet]. SRZEDNICKA-CHRZANOWSKA K Klin Oczna; 1958; 28(2):165-8. PubMed ID: 13550728 [No Abstract] [Full Text] [Related]
3. Conjunctival staining and corneal and conjunctival abrasions caused by 2% aqueous gentian violet solution. Pessah A; Ofosu JR; Klein BL Pediatr Emerg Care; 1998 Aug; 14(4):285-6. PubMed ID: 9733255 [No Abstract] [Full Text] [Related]
4. Descemet-stripping automated endothelial keratoplasty (DSAEK): effect of nontoxic gentian violet marking pen on DSAEK donor tissue viability by using vital dye assay. Ide T; Yoo SH; Kymionis GD; Perez VL; Goldman JM; O'Brien TP Cornea; 2008 Jun; 27(5):562-4. PubMed ID: 18520506 [TBL] [Abstract][Full Text] [Related]
5. The intraoperative "ink test": a novel assessment tool in mitral valve repair. Anyanwu AC; Adams DH J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1635-6. PubMed ID: 17532968 [No Abstract] [Full Text] [Related]
6. Dermal contact dermatitis; sensitivity to rivanol and gentian violet. EPSTEIN S Dermatologica; 1958 Nov; 117(5):287-96. PubMed ID: 13609213 [No Abstract] [Full Text] [Related]
7. [FATAL POISONING CAUSED BY THE USE OF STAMPING INK INSTEAD OF GENTIAN VIOLET IN VAGINAL THERAPY]. ERBEN J; PODDANY V; ROTREKL V Arch Toxikol; 1963 Dec; 20():141-7. PubMed ID: 14114475 [No Abstract] [Full Text] [Related]
8. Gentian violet in the treatment of oral candidiasis. Leung AK Pediatr Infect Dis J; 1988 Apr; 7(4):304-5. PubMed ID: 3368270 [No Abstract] [Full Text] [Related]
9. [Generalized reactions (cyanosis, cardiovascular collapse) caused by sensitization to an aqueous solution of gentian violet and methyl green applied locally]. MICHEL PJ; BUYER R; DELORME Bull Soc Fr Dermatol Syphiligr; 1958; 65(2):183. PubMed ID: 13573078 [No Abstract] [Full Text] [Related]
10. Keratoconjunctivitis sicca following instillation of gentian violet. Dhir SP; Sharma SK; Munjal VP; Gupa A Indian J Ophthalmol; 1982 Jan; 30(1):21-22. PubMed ID: 7141584 [No Abstract] [Full Text] [Related]
11. Accidents of a general nature (cyanosis, cardiovascular collapse) caused by sensitization to aqueous solution of gentian violet & methyl green in local administration. MICHEL PJ; BUYER R; DELORME Lyon Med; 1958 Nov; 90(46):798-9. PubMed ID: 13612300 [No Abstract] [Full Text] [Related]
13. [Response to letter to the editor 23(1): 53, 1990: Risk of cancer development in recipients of gentian violet-treated blood. Validity of the interview]. Luquetti AO Rev Soc Bras Med Trop; 1990; 23(4):237-8. PubMed ID: 2133593 [No Abstract] [Full Text] [Related]
15. [The treatment of methyl violet erosions of the eye]. SCHIRMER R Med Klin; 1953 Jul; 48(27):959-60. PubMed ID: 13086335 [No Abstract] [Full Text] [Related]
16. [Use of methylrosaniline (gentian violet) to treat candidiasis]. Swart EL; van der Waal I Ned Tijdschr Geneeskd; 2004 Apr; 148(14):688. PubMed ID: 15106322 [No Abstract] [Full Text] [Related]
17. Management of the umbilicus with crystal violet solution. Bale MS Can Med Assoc J; 1981 Feb; 124(4):372-3. PubMed ID: 7214266 [No Abstract] [Full Text] [Related]